Glemont 10mg Tablet

Glemont 10mg Tablet contains montelukast, a leukotriene receptor antagonist used for the prevention and long-term control of asthma symptoms and for relief of symptoms of allergic rhinitis (seasonal or year-round nasal allergy symptoms) in adults and adolescents. It works by blocking leukotrienes, chemicals in the body that cause airway inflammation, swelling, and excess mucus production.

Glemont 10mg Tablet is a prescription-only medicine in Malaysia. It is only supplied after an online consultation with a doctor through DoctorOnCall, who will assess your asthma or allergy history and other medicines before issuing a prescription. It is used for ongoing prevention of asthma symptoms and is not a reliever medicine for a sudden asthma attack.

Montelukast selectively blocks the cysteinyl leukotriene receptor (CysLT1) in the airway, preventing leukotrienes released during an allergic or inflammatory response from binding to their receptor. This reduces airway inflammation, bronchoconstriction, swelling of the airway lining, and excess mucus production, helping to prevent asthma symptoms and ease nasal allergy symptoms.

Glemont 10mg Tablet should only be taken according to the dose and schedule prescribed by your doctor following an online consultation with DoctorOnCall. The tablet is usually swallowed whole with water once daily in the evening, with or without food. It should be taken regularly, even when you feel well, as it works to prevent symptoms rather than relieve a sudden attack.

The dosage of Glemont 10mg Tablet is determined individually by your prescribing doctor, and for adults and adolescents it typically involves one tablet taken once a day in the evening as a preventive treatment. Always follow the exact dose and schedule given on your prescription, and do not use it to treat a sudden asthma attack, as it does not provide immediate relief.

Glemont 10mg Tablet is generally stable for up to 24 to 36 months from the date of manufacture when stored correctly and unopened. Always check the expiry date printed on the blister strip or carton before use, and do not take the tablets if the date has passed.

Store Glemont 10mg Tablet at room temperature, below 30 degrees Celsius, in a dry place away from direct sunlight and moisture, and keep it in the original packaging to protect it from light. Keep out of reach of children.

• Known hypersensitivity to montelukast or any ingredient in the tablet
• Not to be used as a reliever for an acute asthma attack or status asthmaticus
• Use with caution in patients with a history of neuropsychiatric symptoms, and report any mood or behaviour changes to the doctor promptly
• Use in pregnancy or breastfeeding only if the doctor considers the benefits outweigh the risks

• Phenobarbital and rifampicin may reduce montelukast blood levels
• Inform your doctor of all other medicines, supplements, and herbal products you are taking
• Montelukast does not need to be timed around meals and can be taken with or without food
• Continue any other prescribed asthma medicines as directed, as Glemont 10mg Tablet is usually used alongside, not instead of, other asthma treatment

• Take Glemont 10mg Tablet once daily in the evening as advised, even when symptoms are well controlled
• Keep a reliever inhaler on hand at all times, as montelukast does not treat sudden breathing difficulty
• Watch for any changes in mood, sleep, or behaviour and report these to your doctor
• Avoid stopping treatment abruptly without consulting your doctor, even if symptoms improve
• Attend scheduled follow-up visits so your doctor can monitor asthma control and adjust treatment if needed

Glemont 10mg Tablet is intended for long-term, preventive control of asthma and allergic rhinitis symptoms in adults and adolescents, and is not a substitute for a fast-acting reliever inhaler during an asthma attack. Regulatory authorities have highlighted that montelukast has been associated with neuropsychiatric side effects such as sleep problems, agitation, or mood changes in some patients, so users and caregivers should be alert to any such changes and discuss them with the doctor. Ongoing follow-up helps the doctor assess how well asthma or allergy symptoms are being controlled and whether treatment needs to be adjusted.